Claudin-2 is unregulated in inflammatory bowel disease (IBD), and its deficiency reduces colitis progression and barrier defect, suggesting that its reduced expression prevents the inflammation of the intestinal barrier (39). The gene discussed is CLDN2; the disease is colitis.